The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Biomarkers of diabetic kidney disease
Open accessAbstract
Diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in diabetes. The quest for both prognostic and surrogate endpoint biomarkers for advanced DKD and end-stage renal disease has received major investment and interest in recent years. However, at present no novel biomarkers are in routine use in the clinic or in trials. This review focuses on the current status of prognostic biomarkers. First, we emphasise that albuminuria and eGFR, with other routine clinical data, show at least modest prediction of future renal status if properly used. Indeed, a major limitation of many current biomarker studies is that they do not properly evaluate the marginal increase in prediction on top of these routinely available clinical data. Second, we emphasise that many of the candidate biomarkers for which there are numerous sporadic reports in the literature are tightly correlated with each other. Despite this, few studies have attempted to evaluate a wide range of biomarkers simultaneously to define the most useful among these correlated biomarkers. We also review the potential of high-dimensional panels of lipids, metabolites and proteins to advance the field, and point to some of the analytical and post-analytical challenges of taking initial studies using these and candidate approaches through to actual clinical biomarker use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749 · cited 6×
“ACR Albumin to creatinine ratio ADMA Asymmetric dimethylarginine ApoA4 Apolipoprotein A4 B2M β2-Microglobulin C1QB Complement C1q subcomponent subunit B CD5L CD5 antigen-like CKD Chronic kidney disease CKD273 CKD classifier based on 273 urinary peptides CKD-EPI Chronic Kidney Disease Epidemiology Collaboration CVD Car…”
BackgroundInfluentialIchimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L., & Sanicola, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4135 · Cited by 1,265
Stevens, L. A., Coresh, J., Schmid, C. H., Feldman, H. I., Froissart, M., Kusek, J., Rossert, J., Van Lente, F., Bruce, R. D., Zhang, Y. (., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.018 · Cited by 1,037
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Factors other than glomerular filtration rate affect serum cystatin C levels
Stevens, L. A., Schmid, C. H., Greene, T., Li, L., Beck, G. J., Joffe, M. M., Froissart, M., Kusek, J. W., Zhang, Y. (., Coresh, J., et al. (2009) · Kidney International · doi:10.1038/ki.2008.638 · Cited by 809
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Michels, W. M., Grootendorst, D. C., Verduijn, M., Elliott, E. G., Dekker, F. W., & Krediet, R. T. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06870909 · Cited by 664
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621 · cited 4×
“SYSKID Systems biology towards novel chronic kidney disease diagnosis and treatment TNFR TNF receptor VEGF Vascular endothelial growth factor Introduction Diabetic kidney disease (DKD) and its most severe manifestation, end-stage renal disease (ESRD), remains one of the leading causes of reduced lifespan in people wit…”
BackgroundInfluentialSelf-citationMetabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y.-H., Wang, L., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020126 · Cited by 571
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Keane, W. F., Brenner, B. M., de Zeeuw, D., Grunfeld, J.-P., McGill, J., Mitch, W. E., Ribeiro, A. B., Shahinfar, S., Simpson, R. L., Snapinn, S. M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00885.x · Cited by 539
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485
Sabbisetti, V. S., Waikar, S. S., Antoine, D. J., Smiles, A., Wang, C., Ravisankar, A., Ito, K., Sharma, S., Ramadesikan, S., Lee, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070758 · Cited by 465
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Livingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S., Leese, G. P., McKnight, J., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 345
Self-citation(1965) · The Lancet · doi:10.1016/s0140-6736(65)92685-1 · Cited by 283
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Self-citationUrinary Proteomics for Early Diagnosis in Diabetic Nephropathy
Zürbig, P., Jerums, G., Hovind, P., MacIsaac, R. J., Mischak, H., Nielsen, S. E., Panagiotopoulos, S., Persson, F., & Rossing, P. (2012) · Diabetes · doi:10.2337/db12-0348 · Cited by 266
Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease
Coca, S. G., Nadkarni, G. N., Huang, Y., Moledina, D. G., Rao, V., Zhang, J., Ferket, B., Crowley, S. T., Fried, L. F., & Parikh, C. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101101 · Cited by 239
Vaidya, V. S., Niewczas, M. A., Ficociello, L. H., Johnson, A. C., Collings, F. B., Warram, J. H., Krolewski, A. S., & Bonventre, J. V. (2011) · Kidney International · doi:10.1038/ki.2010.404 · Cited by 234
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients
Delić, D., Eisele, C., Schmid, R., Baum, P., Wiech, F., Gerl, M., Zimdahl, H., Pullen, S. S., & Urquhart, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150154 · Cited by 228
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Niewczas, M. A., Sirich, T. L., Mathew, A. V., Skupien, J., Mohney, R. P., Warram, J. H., Smiles, A., Huang, X., Walker, W., Byun, J., et al. (2014) · Kidney International · doi:10.1038/ki.2013.497 · Cited by 225
Ekinci, E. I., Jerums, G., Skene, A., Crammer, P., Power, D., Cheong, K. Y., Panagiotopoulos, S., McNeil, K., Baker, S. T., Fioretto, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2572 · Cited by 223
Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
Krolewski, A. S. (2015) · Diabetes Care · doi:10.2337/dc15-0184 · Cited by 220
Clinical predictive factors in diabetic kidney disease progression
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12533 · Cited by 208
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Menon, V., Shlipak, M. G., Wang, X., Coresh, J., Greene, T., Stevens, L., Kusek, J. W., Beck, G. J., Collins, A. J., Levey, A. S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00004 · Cited by 204
Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy
Hirayama, A., Nakashima, E., Sugimoto, M., Akiyama, S.-I., Sato, W., Maruyama, S., Matsuo, S., Tomita, M., Yuzawa, Y., & Soga, T. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6412-x · Cited by 191
Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection
Rosolowsky, E. T., Skupien, J., Smiles, A. M., Niewczas, M., Roshan, B., Stanton, R., Eckfeldt, J. H., Warram, J. H., & Krolewski, A. S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040354 · Cited by 191
Diabetic kidney disease with and without albuminuria
MacIsaac, R. J., & Jerums, G. (2011) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3283456546 · Cited by 189
Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study
Jim, B., Ghanta, M., Qipo, A., Fan, Y., Chuang, P. Y., Cohen, H. W., Abadi, M., Thomas, D. B., & He, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036041 · Cited by 184
Kamijo-Ikemori, A., Sugaya, T., Yasuda, T., Kawata, T., Ota, A., Tatsunami, S., Kaise, R., Ishimitsu, T., Tanaka, Y., & Kimura, K. (2011) · Diabetes Care · doi:10.2337/dc10-1392 · Cited by 167
Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
Argyropoulos, C., Wang, K., McClarty, S., Huang, D. Y. C., Bernardo, J., Ellis, D., Orchard, T. J., Galas, D. J., & Johnson, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054662 · Cited by 166
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
Looker, H. C., Colombo, M., Hess, S., Brosnan, M. J., Farran, B., Dalton, R. N., Wong, M. C., Turner, C., Palmer, C. N. A., Nogoceke, E., et al. (2015) · Kidney International · doi:10.1038/ki.2015.199 · Cited by 162
Self-citationThe genetics of diabetic complications
Ahlqvist, E., van Zuydam, N. R., Groop, L., & McCarthy, M. I. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.37 · Cited by 162
Pena, M. J., Heerspink, H. J. L., Hellemons, M. E., Friedrich, T., Dallmann, G., Lajer, M., Bakker, S. J. L., Gansevoort, R. T., Rossing, P. R., de Zeeuw, D., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12447 · Cited by 162
CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
Argilés, À., Siwy, J., Duranton, F., Gayrard, N., Dakna, M., Lundin, U., Osaba, L., Delles, C., Mourad, G., Weinberger, K. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062837 · Cited by 160
van der Kloet, F. M., Tempels, F. W. A., Ismail, N., van der Heijden, R., Kasper, P. T., Rojas-Cherto, M., van Doorn, R., Spijksma, G., Koek, M., van der Greef, J., et al. (2012) · Metabolomics · doi:10.1007/s11306-011-0291-6 · Cited by 160
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes
Teumer, A., Tin, A., Sorice, R., Gorski, M., Yeo, N. C., Chu, A. Y., Li, M., Li, Y., Mijatovic, V., Ko, Y.-A., et al. (2016) · Diabetes · doi:10.2337/db15-1313 · Cited by 160
Fibroblast Growth Factor 21 Improves Insulin Resistance and Ameliorates Renal Injury in db/db Mice
Kim, H. W., Lee, J. E., Cha, J. J., Hyun, Y. Y., Kim, J. E., Lee, M. H., Song, H. K., Nam, D. H., Han, J., Han, S. Y., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2276 · Cited by 150
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
Roscioni, S. S., de Zeeuw, D., Hellemons, M. E., Mischak, H., Zürbig, P., Bakker, S. J. L., Gansevoort, R. T., Reinhard, H., Persson, F., Lajer, M., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2755-2 · Cited by 150
Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
Jardine, M., Hata, J., Woodward, M., Perkovic, V., Ninomiya, T., Arima, H., Zoungas, S., Cass, A., Patel, A. A., Marre, M., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.025 · Cited by 146
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
Simpson, K., Wonnacott, A., Fraser, D. J., & Bowen, T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0724-8 · Cited by 146
SKUPIEN, J. K., Warram, J. H., Smiles, A. M., Niewczas, M. A., Gohda, T., Pezzolesi, M. G., Cantarovich, D., Stanton, R. C., & Królewski, A. S. (2012) · Kidney International · doi:10.1038/ki.2012.189 · Cited by 145
Han, L., Xia, J., Liang, Q.-L., Wang, Y., Wang, Y.-M., Hu, P., Li, P., & Luo, G. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.01.034 · Cited by 144
Eissa, S., Matboli, M., Aboushahba, R. M. R. M. M., Bekhet, M. M., & Soliman, Y. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.012 · Cited by 134
Pavkov, M. E., Nelson, R. G., Knowler, W. C., Cheng, Y. J., Królewski, A. S., & Niewczas, M. A. (2014) · Kidney International · doi:10.1038/ki.2014.330 · Cited by 131
A urinary proteome-based classifier for the early detection of decline in glomerular filtration
Pontillo, C., Jacobs, L., Staessen, J. A., Schanstra, J. P., Rossing, P. R., Heerspink, H. J. L., Siwy, J., Mullen, W., Vlahou, A., Mischak, H., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw239 · Cited by 130
Lindhardt, M. K., Persson, F., Currie, G. E., Pontillo, C., Beige, J., Delles, C., von der Leyen, H. E., Mischak, H., Navis, G. J., Noutsou, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010310 · Cited by 122
Siwy, J., Schanstra, J. P., Argilés, À., Bakker, S. J. L., Beige, J., Bouček, P., Brand, K., Delles, C., Duranton, F., Fernández‐Fernández, B., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu039 · Cited by 121
Niewczas, M. A., Mathew, A. V., Croall, S., Byun, J., Major, M., Sabisetti, V. S., Smiles, A. M., Bonventre, J. V., Pennathur, S., & Królewski, A. S. (2017) · Diabetes Care · doi:10.2337/dc16-0173 · Cited by 117
Lindhardt, M. K., Persson, F., Zürbig, P., Stalmach, A., Mischak, H., de Zeeuw, D., Heerspink, H. J. L., Klein, R., Orchard, T. J., Porta, M., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw292 · Cited by 113
Serum Levels of the Adipokine FGF21 Depend on Renal Function
Stein, S., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stümvoll, M., & Faßhauer, M. (2008) · Diabetes Care · doi:10.2337/dc08-1054 · Cited by 112
Titan, S., Vieira, J. M., Dominguez, W. V., Moreira, S. R. S., Pereira, A. B., Barros, R. T., & Zatz, R. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.006 · Cited by 111
Diabetic nephropathy: landmark clinical trials and tribulations
Chan, G. C. W., & Tang, S. C. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu411 · Cited by 109
Fufaa, G. D., Weil, E. J., Nelson, R. G., Hanson, R. L., Bonventre, J. V., Sabbisetti, V. S., Waikar, S. S., Mifflin, T. E., Zhang, X., Xie, D., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3389-3 · Cited by 107
Barutta, F., Bruno, G., Matullo, G., Chaturvedi, N., Grimaldi, S., Schalkwijk, C. G., Stehouwer, C. D. A., Fuller, J., & Gruden, G. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0915-4 · Cited by 107
Panduru, N. M., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Bierhaus, A., Humpert, P. M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc12-1868 · Cited by 106
Nielsen, S. E., Reinhard, H., Zdunek, D., Heß, G., Gutiérrez, O. M., Wolf, M. S., Parving, H., Jacobsen, P. K., & Rossing, P. R. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.007 · Cited by 101
Nielsen, S. E., Andersen, S., Zdunek, D., Heß, G., Parving, H., & Rossing, P. R. (2011) · Kidney International · doi:10.1038/ki.2010.554 · Cited by 99
Araki, S., Haneda, M., Koya, D., Sugaya, T., Isshiki, K., Kume, S., Kashiwagi, A., Uzu, T., & Maegawa, H. (2012) · Diabetes Care · doi:10.2337/dc12-1298 · Cited by 98
Argyropoulos, C., Wang, K., Bernardo, J., Ellis, D., Orchard, T. J., Galas, D. J., & Johnson, J. P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071498 · Cited by 95
Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes
Elley, C. R., Robinson, T., Moyes, S. A., Kenealy, T. W., Collins, J. F., Robinson, E., Orr‐Walker, B., & Drury, P. (2013) · Diabetes Care · doi:10.2337/dc13-0190 · Cited by 94
Boertien, W. E., Riphagen, I. J., Drion, I., Alkhalaf, A., Bakker, S. J. L., Groenier, K. H., Struck, J., de Jong, P. E., Bilo, H. J. G., Kleefstra, N., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2922-0 · Cited by 92
Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0683 · Cited by 89
Peng, H., Zhong, M., Zhao, W., Wang, C., Zhang, J., Liu, X., Li, Y., Paudel, S. D., Wang, Q., & Lou, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082607 · Cited by 89
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
Pena, M. J., Mischak, H., & Heerspink, H. J. L. (2016) · Diabetologia · doi:10.1007/s00125-016-4001-9 · Cited by 89
Panduru, N. M., Sandholm, N., Forsblom, C. M., Saraheimo, M., Dahlström, E. H., Thorn, L. M., Gordin, D., Tolonen, N., Wadén, J., Harjutsalo, V., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2330 · Cited by 88
Peters, K. E., Davis, W. A., Ito, J., Winfield, K., Stoll, T. M., Bringans, S., LIPSCOMBE, R. J., & Davis, T. M. E. (2017) · Diabetes Care · doi:10.2337/dc17-0911 · Cited by 85
Wu, C., Wang, Q., Lv, C., Qin, N., Lei, S., Yuan, Q., & Wang, G. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.026 · Cited by 83
Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Cleary, P. A., Klein, R. L., & Virella, G. (2013) · Diabetes Care · doi:10.2337/dc12-2521 · Cited by 82
A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus
Ng, D., Salim, A., Liu, Y., Zou, L., Xu, F., Huang, S. H., Leong, H., & Ong, C. N. (2011) · Diabetologia · doi:10.1007/s00125-011-2339-6 · Cited by 79
Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes
Bhensdadia, N. M., Hunt, K. J., Lopes-Virella, M. F., Tucker, J. M., Mataria, M. R., Alge, J. L., Neely, B. A., Janech, M. G., & Arthur, J. M. (2013) · Kidney International · doi:10.1038/ki.2013.57 · Cited by 77
Klein, R. L., Hammad, S. M., Baker, N. L., Hunt, K. J., Gadban, M. M. A., Cleary, P. A., Virella, G., & Lopes-Virella, M. F. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.001 · Cited by 77
Improved prognosis of diabetic nephropathy in type 1 diabetes
Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H., Hovind, P. H., Hansen, T. W., & Rossing, P. R. (2014) · Kidney International · doi:10.1038/ki.2014.206 · Cited by 75
Pavkov, M. E., Weil, E. J., Fufaa, G. D., Nelson, R. G., Lemley, K. V., Knowler, W. C., Niewczas, M. A., & Królewski, A. S. (2015) · Kidney International · doi:10.1038/ki.2015.278 · Cited by 75
Agarwal, R., Duffin, K. L., Laska, D. A., Voelker, J. R., Breyer, M. D., & Mitchell, P. G. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu255 · Cited by 74
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
Verhave, J. C., Bouchard, J., Goupil, R., Pichette, V., Brachemi, S., Madore, F., & Troyanov, S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.006 · Cited by 72
Han, S. H., Choi, S. H., Cho, B. J., Lee, Y., Lim, S. K., Park, Y. J., Moon, M. K., Lee, H. K., Kang, S., Han, D. S., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.018 · Cited by 71
Petrică, L., Vlad, A., Gluhovschi, G., Gădălean, F., Dumitraşcu, V., Gluhovschi, C. A., Velciov, S. M., Bob, F. R., Vlad, M., Popescu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112538 · Cited by 70
Pena, M. J., Heinzel, A., Heinze, G., Alkhalaf, A., Bakker, S. J. L., Nguyen, T. Q., Goldschmeding, R., Bilo, H. J. G., Perco, P., Mayer, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120995 · Cited by 70
Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration
Fu, W., Li, B.-L., Wang, S., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.031 · Cited by 70
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
Vergouwe, Y., Soedamah‐Muthu, S. S., Zgibor, J. C., Chaturvedi, N., Forsblom, C. M., Snell‐Bergeon, J. K., Maahs, D. M., Groop, P., Rewers, M., Orchard, T. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1585-3 · Cited by 69
Conway, B. R., Manoharan, D., Manoharan, D., Jenks, S. J., Dear, J. W., McLachlan, S., Strachan, M. W. J., & Price, J. F. (2012) · Kidney International · doi:10.1038/ki.2012.218 · Cited by 68
Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
Królewski, A. S., Warram, J. H., Forsblom, C. M., Smiles, A. M., Thorn, L. M., SKUPIEN, J. K., Harjutsalo, V., Stanton, R. C., Eckfeldt, J. H., Inker, L. A., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2220 · Cited by 68
Velho, G., Boustany, R. E., Lefèvre, G., Mohammedi, K., Fumeron, F., Potier, L., Bankir, L., Bouby, N., Hadjadj, S., Marre, M., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1003 · Cited by 67
Use of Proteomics To Investigate Kidney Function Decline over 5 Years
Carlsson, A. C., Ingelsson, E., Sundström, J., Carrero, J. J., Gustafsson, S., Feldreich, T., Stenemo, M., Larsson, A. O., Lind, L., & Ärnlöv, J. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08780816 · Cited by 67
Schlatzer, D., Maahs, D. M., Chance, M. R., Dazard, J.-E., Li, X., Hazlett, F. E., Rewers, M., & Snell‐Bergeon, J. K. (2012) · Diabetes Care · doi:10.2337/dc11-1491 · Cited by 66
Waikar, S. S., Sabbisetti, V. S., Ärnlöv, J., Carlsson, A. C., Coresh, J., Feldman, H. I., Foster, M. C., Fufaa, G. D., Helmersson‐Karlqvist, J., Hsu, C., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw203 · Cited by 65
Novel urinary biomarkers in pre-diabetic nephropathy
Garg, V., Kumar, M., Mahapatra, H. S., Chitkara, A., Gadpayle, A. K., & Sekhar, V. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1085-3 · Cited by 62
SKUPIEN, J. K., Warram, J. H., Smiles, A. M., Stanton, R. C., & Królewski, A. S. (2016) · Diabetes Care · doi:10.2337/dc16-0950 · Cited by 61
Saulnier, P., Gand, E., Velho, G., Mohammedi, K., Zaoui, P., Fraty, M., Halimi, J., Roussel, R., Ragot, S., & Hadjadj, S. (2016) · Diabetes Care · doi:10.2337/dc16-1571 · Cited by 61
Bidadkosh, A., Lambooy, S., Heerspink, H. J. L., Pena, M. J., Henning, R. H., Buikema, H., & Deelman, L. E. (2017) · Diabetes Care · doi:10.2337/dc16-2175 · Cited by 61
Association between serum fibroblast growth factor 21 and diabetic nephropathy
Jian, W., Peng, W., Jin, J., Chen, X., Fang, W., Wang, W., Li, Q., Dong, Y., & Su, Q. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.012 · Cited by 57
Metabolomic biomarkers in diabetic kidney diseases—A systematic review
Zhang, Y., Zhang, S., & Wang, G. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.06.016 · Cited by 56
Foster, M. C., Inker, L. A., Hsu, C., Eckfeldt, J. H., Levey, A. S., Pavkov, M. E., Myers, B. D., Bennett, P. H., Kimmel, P. L., Vasan, R. S., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.013 · Cited by 56
Forsblom, C. M., Moran, J. L., Harjutsalo, V., Loughman, T., Wadén, J., Tolonen, N., Thorn, L. M., Saraheimo, M., Gordin, D., Groop, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0225 · Cited by 54
Lindhardt, M. K., Persson, F., Oxlund, C. S., Jacobsen, I. A., Zürbig, P., Mischak, H., Rossing, P. R., & Heerspink, H. J. L. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw406 · Cited by 54
Hui, E., Yeung, C., Lee, P. C. H., Woo, Y. C., Fong, C. H.-Y., Chow, W.-S., Xu, A., & Lam, K. S. L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2235 · Cited by 53
Mayer, G. J., Heerspink, H. J. L., Aschauer, C., Heinzel, A., Heinze, G., Kainz, A., Sunzenauer, J., Perco, P., de Zeeuw, D., Rossing, P. R., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2202 · Cited by 53
Yamanouchi, M., SKUPIEN, J. K., Niewczas, M. A., Smiles, A. M., Doria, A., Stanton, R. C., Gałecki, A. T., Duffin, K. L., Pullen, N., Breyer, M. D., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.010 · Cited by 47
Lee, J. E., Gohda, T., Walker, W. H., SKUPIEN, J. K., Smiles, A. M., Holak, R. R., Jeong, J., McDonnell, K. P., Królewski, A. S., & Niewczas, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058007 · Cited by 46
Pikkemaat, M., Melander, O., & Boström, K. B. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.006 · Cited by 45
Merchant, M. L., Niewczas, M. A., Ficociello, L., Lukenbill, J. A., Wilkey, D. W., Li, M., Khundmiri, S. J., Warram, J. H., Królewski, A. S., & Klein, J. B. (2013) · Kidney International · doi:10.1038/ki.2013.8 · Cited by 40
Burns, K. D., Lytvyn, Y., Mahmud, F. H., Daneman, D., Deda, L., Dunger, D. B., Deanfield, J. E., Dalton, R. N., Elia, Y. T., Har, R. L. H., et al. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00438.2016 · Cited by 40
Bouvet, B. R., Paparella, C. V., Arriaga, S. M. M., et al. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003010 · Cited by 39
Cherney, D. Z. I., Scholey, J. W., Daneman, D., Dunger, D. B., Dalton, R. N., Moineddin, R., Mahmud, F. H., Dekker, R., Elia, Y. T., Sochett, E. B., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03651.x · Cited by 34
Wang, Y., Li, Y., Zhang, S., Zhao, J., & Liu, C. (2016) · Journal of International Medical Research · doi:10.1177/0300060515601699 · Cited by 34
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
Dieter, B. P., McPherson, S., Afkarian, M., de Boer, I. H., Mehrotra, R., Short, R., Barbosa‐Leiker, C., Alicic, R. Z., Meek, R. L., & Tuttle, K. R. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.018 · Cited by 30
Pena, M. J., Jankowski, J., Heinze, G., Kohl, M., Heinzel, A., Bakker, S. J. L., Gansevoort, R. T., Rossing, P. R., de Zeeuw, D., Heerspink, H. J. L., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000685 · Cited by 27
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy
Pena, M. J., de Zeeuw, D., Andress, D. L., Brennan, J. J., Correa‐Rotter, R., Coll, B., Kohan, D. E., Makino, H., Perkovic, V., Remuzzi, G., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12864 · Cited by 27
Barr, E. L., Maple-Brown, L. J., Barzi, F., Hughes, J. T., Jerums, G., Ekinci, E. I., Ellis, A. G., Jones, G. R. D., Lawton, P. D., Sajiv, C., et al. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.11.024 · Cited by 25
Bjornstad, P., Pyle, L., Cherney, D. Z. I., Johnson, R. J., Sippl, R., Wong, R., Rewers, M., & Snell‐Bergeon, J. K. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx255 · Cited by 24
Molecular disease presentation in diabetic nephropathy
Heinzel, A., Mühlberger, I., Stelzer, G., Lancet, D., Oberbauer, R. W., Martin, M. J., & Perco, P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv267 · Cited by 21
Har, R. L. H., Reich, H. N., Scholey, J. W., Daneman, D., Dunger, D. B., Moineddin, R., Dalton, R. N., Motran, L., Elia, Y. T., Deda, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111131 · Cited by 20
Functional Molecular Units for Guiding Biomarker Panel Design
Heinzel, A., Mühlberger, I., Fechete, R., Mayer, B., & Perco, P. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0709-0_7 · Cited by 18
Antonellis, P. J., Kharitonenkov, A., & Adams, A. C. (2014) · Journal of Animal Science · doi:10.2527/jas.2013-7076 · Cited by 17
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
The single-cell transcriptomic landscape of early human diabetic nephropathy
Wilson, P. C., Wu, H., Kirita, Y., Uchimura, K., Ledru, N., Rennke, H. G., Welling, P. A., Waikar, S. S., & Humphreys, B. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908706116 · Cited by 539
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Jung, C.-Y., & Yoo, T.-H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0329 · Cited by 262
Sabanayagam, C., He, F., Nusinovici, S., Li, J., Lim, C., Tan, G., & Cheng, C. Y. (2023) · eLife · doi:10.7554/elife.81878 · Cited by 51
He, F., Ng Yin Ling, C., Nusinovici, S., Cheng, C.-Y., Wong, T. Y., Li, J., & Sabanayagam, C. (2024) · Journal of Medical Internet Research · doi:10.2196/41065 · Cited by 29
Metadata
- Authors
- Colhoun, H. M., & Marcovecchio, M. L.
- Venue
- Diabetologia
- Published
- 2018-03-08
- Volume
- 61
- Issue
- 5
- Pages
- 996-1011
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2790272775
- Cited by
- 270
- References
- 117
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.